Spotlight: "Telehealth-supported ketamine for depression and anxiety: A systematic review (2026)
"Telehealth-supported sublingual racemic ketamine was associated with symptom improvements in selected populations"
https://journals.sagepub.com/doi/10.1177/10398562261458880
"Of 3,857 records screened, three met criteria, all from US commercial providers. Programmes differed in dosing schedules, clinical staffing, supervision, and safety monitoring. Across up to 16,876 patients, follow-up outcome data were available for a minority. Response ranged 49.5–62.8% (PHQ-9) and 47.6–62.9% (GAD-7), and remission 20.7–32.6% and 23.9–31.3%, respectively."
See also:
Telehealth in Psychotherapy
Psychedelic mental health resources to prepare and integrate your individual experience via Telehealth
Michael DeMarco, PhD
Telehealth Integration in Ketamine Treatment Programs: Opportunities, Limitations, and Emerging…
Introduction
Dr. Austin Harris
Guidelines for the Personal and Clinical Use of Ketamine – Multidisciplinary Association for Psychedelic Studies – MAPS
